$2.7 Bn NGS Sample Preparation Market, 2024 by Product, Workflow, Application, & Technology - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--May 16, 2019--
The “NGS Sample Preparation Market by Product (Reagent, Workstations), Workflow (Library Preparation [DNA, RNA], Target Enrichment), Application (Infectious Disease, Cancer Diagnostics), Technology (SMRT, Nanopore) - Forecast to 2024” report has been added to ResearchAndMarkets.com’s offering.
The NGS sample preparation market is projected to reach USD 2.7 billion by 2024 from USD 1.1 billion in 2019, at a CAGR of 18.7% during the forecast period.
The growth of this market is driven by increasing application of NGS in diagnostics and genomics research, increasing adoption of NGS for diagnostics (due to the decreasing cost of NGS products and services), and development of low-cost sequencing technologies are expected to drive the market growth in the future.
The library preparation products segment to register the highest CAGR in the NGS reagents and consumables market.
Based on workflow, the reagents & consumables segment is subsegmented into library preparation, target enrichment, and quality control. Library preparation segment is classified into DNA (Human WGS, targeted sequencing, whole exome sequencing, and others) and RNA (gene expression analysis, whole transcriptome, and others) on the basis of type.
In 2018, the library preparation segment accounted for the largest share of the NGS reagents and consumables market. Advancements in the NGS protocols for library preparation and the increasing number of research activities are driving the growth of the library preparation market.
The academic institutes & research centers segment is expected to dominate the end-user segment.
Based on end user, the NGS sample preparation market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. The academic institutes & research centers segment is expected to account for the largest share the NGS sample preparation market during the forecast period.
The increasing number of collaborations between NGS market players and academic & research institutions; availability of financial support for genomics R&D across regions; and the development of cost-effective NGS products and services for researchers are the major factors supporting the growth of this end-user segment.
The NGS sample preparation market in the APAC is projected to grow at the highest rate during the forecast period.
The Asia Pacific NGS sample preparation market is expected to witness the highest CAGR from 2019 to 2024. Increasing financial support from public as well as private agencies, increasing number of NGS-based research projects, increasing awareness about precision medicine, and high incidence of chronic diseases in key APAC countries are the major factors driving the growth of this regional market.
Several companies such as Illumina Inc. (US), Thermo Fisher Scientific (US), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (US), and Beckman Coulter (a subsidiary of Danaher), among others, are investing in high-growth markets to gain significant profits and increase their share in the NGS sample preparation market.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 NGS Sample Preparation: Market Overview
4.2 NGS Sample Preparation Market Share, By Product, 2018
4.3 Market, By End User, 2019 vs. 2024 (USD Million)
4.4 Market, By Application, 2019 vs. 2024 (USD Million)
4.5 Market, By Region
5 Market Overview
5.2 Market Dynamics
184.108.40.206 Advancements in NGS Platforms
220.127.116.11 Declining Cost of Sequencing
18.104.22.168 Improving Reimbursement Scenario for NGS-Based Diagnostic Tests
22.214.171.124 End User Budget Constraints in Developing Countries
126.96.36.199 Initiatives and Funding From Government & Private Bodies for Large-Scale Sequencing Projects
188.8.131.52 Increasing Applications of NGS
184.108.40.206 Ethical Issues
6 NGS Sample Preparation Market, By Product
6.2 Reagents & Consumables
6.2.1 Rising Adoption of NGS is Supporting the Use of NGS Reagents and Consumables
6.3 NGS Workstations
6.3.1 High Throughput and Reduction in Hands-On Time Ensures the Adoption of Workstations in NGS Workflow
7 NGS Reagents and Consumables Market, By Workflow
7.2 Library Preparation
7.2.1 DNA Fragmentation, End Repair, A-Tailing, and Size Selection
220.127.116.11 Availability of Products From Various Players Drives the Market for This Segment
7.2.2 DNA Library Preparation
18.104.22.168 Whole Exome Sequencing
22.214.171.124 Targeted Sequencing
126.96.36.199 Whole Genome Sequencing
7.2.3 RNA Library Preparation
188.8.131.52 Gene Expression Analysis
184.108.40.206 Whole Transcriptome Sequencing
220.127.116.11 Other RNA Applications
7.3 Target Enrichment
7.3.1 Targeted Sequencing
7.3.2 Whole Exome Sequencing
7.4 Quality Control
7.4.1 Importance of Quality Control Step in the NGS Workflow & Rising Number of Research Activities Using NGS Technology are the Key Factors Driving Market Growth
8 NGS Library Preparation & Target Enrichment Market, By Technology
8.2 Sequencing By Synthesis (Sbs)
8.2.1 Sbs has A Wide Customer Base Owing to Its Well-Established Precision in Sequencing as Well as Its Broad Application Base
8.3 Ion Semiconductor Sequencing
8.3.1 Extensive Applications of Ion Semiconductor Sequencing to Drive Market Growth
8.4 Single-Molecule Real-Time Sequencing (Smrt)
8.4.1 High Cost of Smrt-Based Platforms to Restrain Market Growth
8.5 Nanopore Sequencing
8.5.1 Small Size and Low Equipment Costs to Support the Adoption of Nanopore Sequencing Platforms By Various End Users
8.6 Other Sequencing Technologies
9 NGS Sample Preparation Market, By Application
9.2.1 Cancer Diagnostics
18.104.22.168 Increasing Cancer Patient Population Across the Globe is Driving This Segment
9.2.2 Infectious Disease Diagnostics
9.2.3 Reproductive Health Diagnostics
9.2.4 Other Disease Diagnostic Applications
9.3 Drug Discovery
9.3.1 Increasing Use of NGS During Clinical Trials for Drug Discovery and Development to Drive the Adoption NGS Sample Preparation Products
9.4 Agricultural & Animal Research
9.4.1 Funding & Support for Animal and Plant Genomics Research to Support the Adoption of NGS Sample Preparation Products
9.5 Other Applications
10 NGS Sample Preparation Market, By End User
10.2 Academic Institutes & Research Centers
10.2.1 Availability of Financial Support for Genomics Research to Support the Growth of This Segment
10.3 Hospitals & Clinics
10.3.1 NGS Technology to Witness Significant Adoption in Disease Diagnosis Owing to Its Advantages Over Conventional Methods
10.4 Pharmaceutical & Biotechnology Companies
10.4.1 Continuous Focus of Pharmaceutical and Biotechnology Companies on Targeted therapies for Precision Medicine to Drive the Growth of ThisEnd-User Segment
10.5 Other End Users
11 NGS Sample Preparation Market, By Region
11.2 North America
11.3.1 Favorable Regulatory and Reimbursement Scenario for NGS-Based Diagnostics Tests in the Country Drives the Market
11.4.1 Favorable Government Funding Scenario in Canada Boost Genomics Research
11.6.1 Strong R&D Base in Germany Supports Market Growth
11.7.1 Use of NGS-Based Test for Disease Diagnosis Will Drive Market Growth
11.8.1 Support for Genomics Research is A Key Driver of Market Growth
11.9 Asia Pacific
11.9.4 Rest of Asia Pacific
11.10 Rest of the World
12 Competitive Landscape
12.2 Market Share Analysis, 2018
12.3 Competitive Scenario
12.4 Vendor Inclusion Criteria
12.5 Competitive Leadership Mapping (Overall Market - 2017)
13 Company Profile
13.1 Agilent Technologies, Inc.
13.2 Becton, Dickinson and Company
13.3 Beckman Coulter (A Subsidiary of Danaher)
13.4 F. Hoffmann-La Roche AG
13.5 Illumina, Inc.
13.6 New England Biolabs, Inc.
13.7 Nugen Technologies, Inc. (Part of Tecan Trading Ag)
13.8 Oxford Gene Technology (Part of Sysmex)
13.9 Oxford Nanopore Technologies, Ltd.
13.10 Pacific Biosciences of California, Inc.
13.11 Perkinelmer, Inc.
13.12 QIAGEN N.V.
13.13 Raindance Technologies, Inc. (Part of Bio-Rad Laboratories)
13.14 Swift Biosciences Inc.
13.15 Thermo Fisher Scientific Inc.
For more information about this report visit https://www.researchandmarkets.com/r/2wdyfa
View source version on businesswire.com:https://www.businesswire.com/news/home/20190516005489/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Laboratory Testing,Molecular Diagnostics
INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES OTHER SCIENCE SCIENCE
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 05/16/2019 07:26 AM/DISC: 05/16/2019 07:26 AM